GLP-1 Baseline Panel
Your starting point before the first injection: blood sugar, cholesterol, pancreas, liver, kidneys, thyroid and nutrients in one measurement.
Lp(a), lipoprotein(a), is an LDL particle with an extra protein, apolipoprotein(a), which your liver cells make; according to the European Atherosclerosis Society (EAS), Lp(a) is also broken down mainly in the liver. Lp(a) carries cholesterol through your blood, just like LDL.
With a high Lp(a), the risk of cardiovascular disease rises gradually according to the EAS, and more than 90% of the differences in Lp(a) between people come from the LPA gene according to the EAS. Which Lp(a) level you have shows only from a blood test.
Star-SHL expresses Lp(a) in nanomoles per litre (nmol/l) and gives < 75 nmol/l as the reference value. Between people, Lp(a) ranges from below 0.2 to 750 nmol/L according to the EAS.
Doctor's Assessment Included
Lp(a) is a fat particle whose level is largely inherited. Laboratories report it in nmol/l or mg/l, so a result can only be compared with the limit of the laboratory that measured it.
| Result | Value (g/l) |
|---|---|
| Normal | < 0,3 |
| Borderline | 0,3–0,5 |
| Elevated | ≥ 0,5 |
Lp(a) is largely inherited and stays almost constant throughout life. The risk rises gradually with the value; the EAS stresses that there is no biological threshold. The NHG guideline CVRM uses > 50 mg/dl (0.50 g/l, 80th percentile) as the cut-off and advises against screening the general population. Some laboratories apply a stricter upper limit (0.3 g/l), which matches the lower end of the EAS grey zone.
Source: Nederlands Huisartsen Genootschap Reference population: Adults (NHG guideline CVRM; EAS 2022)
Source: European Atherosclerosis Society Reference population: Adults (NHG guideline CVRM; EAS 2022)
Reference ranges may vary between laboratories. When you order a test, a BIG-registered doctor assesses your personal results in context. For treatment decisions, discuss your results with your GP.
The upper limit runs from 60 nmol/l at Unilabs to 75 nmol/l at Star-shl.
| Laboratory | Group | Reference value (nmol/l) | Relative scale |
|---|---|---|---|
| Star-shl | · Everyone · a limit, not a range | < 75 nmol/l |
75
|
| Unilabs | · Everyone · a limit, not a range | < 60 nmol/l |
60
|
| Unilabs | · Everyone · grey zone for cardiovascular disease | 75–125 nmol/l |
75 125
|
| Unilabs | · Everyone · a limit, not a range · raised risk of cardiovascular disease | > 125 nmol/l |
125
|
| Certe | · Everyone · 18 years and older · a limit, not a range | < 500 mg/L mg/L | |
| Certe | · Everyone · grey zone | 300–500 mg/L mg/L | |
| Certe | · Everyone · a limit, not a range · high risk | > 500 mg/L mg/L | |
| Diagnostiek voor U | · Everyone · a limit, not a range | < 75 nmol/L |
75
|
Source: Star-shl
Source: Unilabs
Source: Certe
Source: Diagnostiek voor U
Each value as the laboratory itself publishes it, retrieved in 2026.
An Lp(a) measurement counts how much lipoprotein(a) is in your serum, at Star-SHL in nanomoles per litre. According to the EAS, the number of Kringle-IV repeats in the LPA gene explains about 30 to 70% of the differences between people, and fewer than 23 repeats gives small apo(a) forms and a markedly higher Lp(a).
The link between Lp(a) and cardiovascular disease is causal according to the EAS and holds across different ethnic backgrounds, with a risk that rises gradually with the value.
The 2022 EAS consensus wants Lp(a) measured at least once in every adult, ideally together with the first lipid profile. The Dutch guideline on inherited dyslipidaemia considers screening the whole population unjustified, and names familial hypercholesterolaemia (FH), inherited high cholesterol, among the reasons to consider a measurement.
A poorly working liver lowers Lp(a) according to the EAS, depending on the cause, and below 75 nmol/l Lp(a) falls within the reference value at Star-SHL.
A high Lp(a) can occur with reduced kidney function according to the EAS: in nephrotic syndrome, a kidney disease with heavy protein loss in the urine, Lp(a) is 3 to 5 times as high as in people without the disease.
Reduced liver function
Lp(a) is made in the liver, so a poorly working liver can lower the level.
Overactive thyroid
An overactive thyroid can lower Lp(a); after treatment the level rises by 20 to 25 percent.
Hormone therapy after menopause
Hormone replacement therapy after menopause lowers Lp(a) by about 25 percent.
Severe acute illness
In life-threatening conditions such as sepsis or severe burns, Lp(a) is lower.
Inherited level
The Lp(a) level is thought to be mainly set by the genes and to barely change from adulthood.
Kidney disease
Reduced kidney function can raise Lp(a), and in nephrotic syndrome the level is 3 to 5 times higher.
Pregnancy
Lp(a) can double during pregnancy.
Underactive thyroid
An underactive thyroid can raise Lp(a); treatment lowers it by 5 to 20 percent.
The EAS wants a high Lp(a) read within the total risk of cardiovascular disease, with early management of the other risk factors through lifestyle. Diet shifts Lp(a) in both directions according to the EAS table of non-genetic influences, by about 10 to 15% up or about 15% down, depending on the type of fat in the diet.
Lp(a) stays the same with fasting: the EAS lists no effect of fasting on the value.
Reduced kidney function can raise Lp(a) according to the EAS, possibly because the liver makes more Lp(a) when protein is lost through the urine or the dialysis fluid, or because Lp(a) is broken down less.
A very low Lp(a) goes together with a higher chance of diabetes according to a meta-analysis cited by the EAS.
These panels measure values from the same category as this marker.
Your starting point before the first injection: blood sugar, cholesterol, pancreas, liver, kidneys, thyroid and nutrients in one measurement.
The 6-month measurement: everything from the check-in plus insulin, ApoB and your nutrients — especially relevant if you have been eating much less for a while.
The 3-month safety and progress check clinics do: pancreas, liver, kidneys, salts and your metabolic progress on GLP-1 medication.
HDL, LDL, total cholesterol and triglycerides — your cholesterol often improves a lot while losing weight. This test makes it visible.
Medical reviewer
Dr. Naimi oversees the medical standards behind our content and assessments.
Medical policyDoctor's Assessment Included
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
Lipoprotein(a)
€36,-
We use cookies to analyze site usage and measure ad effectiveness. Privacy Policy